Related Experiment Video

Updated: Apr 27, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.2K

Brain metastasis: new opportunities to tackle therapeutic resistance

Joan Seoane1, Leticia De Mattos-Arruda2

  • 1Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain.

Molecular Oncology
|June 24, 2014
PubMed

Insights

Brain metastasis is a growing cancer challenge. Understanding its unique traits is key to developing new treatments and improving patient outcomes.

Area of Science:

  • Oncology
  • Neuroscience
  • Cancer Biology

Background:

  • Brain metastasis is an increasing complication of cancer with limited treatment options.
  • The unique tumor microenvironment of the brain, including the blood-brain barrier, presents significant therapeutic challenges.
  • Despite advances in systemic cancer therapy, outcomes for patients with brain metastases remain poor.

Purpose of the Study:

  • To review the current understanding of brain metastasis characteristics.
  • To explore the implications of these characteristics in therapeutic resistance.
  • To discuss the potential for developing biomarkers for targeted therapy.

Main Methods:

  • Literature review of current research on brain metastasis.
  • Analysis of the unique biological and immunological features of the brain microenvironment.
  • Synthesis of information on therapeutic resistance mechanisms.

Main Results:

  • Brain metastasis possesses distinct biological features that contribute to treatment resistance.
  • The blood-brain barrier and the brain's immune system create a protective niche for metastatic cells.
  • Current systemic therapies often show limited efficacy against brain metastases.

Conclusions:

  • Further research into the molecular alterations in brain metastases is crucial.
  • Identifying novel therapeutic targets and understanding resistance mechanisms are essential.
  • Biomarker development can guide the rational use of targeted agents for brain metastasis.
Keywords:
Brain metastasisTargeted therapyTherapeutic resistance

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

6.5K
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.4K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K